HDAC9 and prostate carcinoma: For a deeper insight into the molecular events underlying the mode of action of SF5-SAHA, we investigated a possible involvement in the induction of the formation of reactive oxygen species (ROS), since HDAC inhibition has already been shown to be linked to ROS induction in solid cancers, including prostate cancer [21].